Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.159
-0.011 (-0.96%)
Mar 9, 2026, 3:27 PM EDT - Market open
Vivani Medical Employees
Vivani Medical had 37 employees as of December 31, 2024. The number of employees decreased by 7 or -15.91% compared to the previous year.
Employees
37
Change (1Y)
-7
Growth (1Y)
-15.91%
Revenue / Employee
n/a
Profits / Employee
-$703,405
Market Cap
92.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37 | -7 | -15.91% |
| Dec 31, 2023 | 44 | -6 | -12.00% |
| Dec 31, 2022 | 50 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Seer, Inc. | 134 |
| PMV Pharmaceuticals | 47 |
| Biomea Fusion | 42 |
| Cassava Sciences | 30 |
| Cognition Therapeutics | 28 |
| iBio, Inc. | 20 |
| TuHURA Biosciences | 19 |
| MAIA Biotechnology | 13 |
VANI News
- 5 weeks ago - Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026 - GlobeNewsWire
- 5 weeks ago - Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewsWire
- 6 weeks ago - Vivani Medical, Inc. Announces Pricing of Common Stock Offering - GlobeNewsWire
- 4 months ago - Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewsWire
- 5 months ago - Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 - GlobeNewsWire
- 6 months ago - Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewsWire
- 6 months ago - Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management - GlobeNewsWire